Bacterial persistence in Legionella pneumophila clinical isolates from patients with recurring legionellosis

Front Cell Infect Microbiol. 2023 Aug 1:13:1219233. doi: 10.3389/fcimb.2023.1219233. eCollection 2023.

Abstract

Bacterial persisters are a transient subpopulation of non-growing, antibiotic-tolerant cells. There is increasing evidence that bacterial persisters play an important role in treatment failure leading to recurring infections and promoting the development of antibiotic resistance. Current research reveals that recurring legionellosis is often the result of relapse rather than reinfection and suggests that the mechanism of bacterial persistence may play a role. The development of single-cell techniques such as the Timerbac system allows us to identify potential persister cells and investigate their physiology. Here, we tested the persister forming capacity of 7 pairs of Legionella pneumophila (Lp) clinical isolates, with isolate pairs corresponding to two episodes of legionellosis in the same patient. We distinguished non-growing subpopulations from their replicating counterparts during infection in an amoeba model. Imaging flow cytometry allowed us to identify single non-growing bacteria within amoeba cells 17 h post-infection, thus corresponding to this subpopulation of potential persister cells. Interestingly the magnitude of this subpopulation varies between the 7 pairs of Lp clinical isolates. Biphasic killing kinetics using ofloxacin stress confirmed the persister development capacity of ST1 clinical isolates, highlighting enhanced persister formation during the host cell infection. Thus, persister formation appears to be strain or ST (sequence type) dependent. Genome sequence analysis was carried out between ST1 clinical isolates and ST1 Paris. No genetic microevolution (SNP) linked to possible increase of persistence capacity was revealed among all the clones tested, even in clones issued from two persistence cycle experiments, confirming the transient reversible phenotypic status of persistence. Treatment failure in legionellosis is a serious issue as infections have a 5-10% mortality rate, and investigations into persistence in a clinical context and the mechanisms involved may allow us to combat this issue.

Keywords: L. pneumophila; amoeba; antibiotic tolerance; bacterial persistence; recurring legionellosis; virulence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Clone Cells
  • Humans
  • Legionella pneumophila* / genetics
  • Legionellosis*
  • Reinfection

Substances

  • Anti-Bacterial Agents

Grants and funding

This work was supported by CNRS (Centre National de la Recherche Scientifique, UMR5308), INSERM (Institut National de la Santé et de la Recherche Médicale; U1111), University Claude Bernard Lyon 1 and HCL (Hospices Civils de Lyon).